Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5 NET 1 Head & Neck 1 Gynecologic 1 Endocrine 1

Conditions

Neuroendocrine Tumors 378 Pituitary Neoplasms 159 Multiple Endocrine Neoplasia Type 1 150 Thyroid Cancer, Papillary 122 Pheochromocytoma 107 Carcinoma, Neuroendocrine 93 Thyroid Neoplasms 74 Paraganglioma 68 Carcinoid Tumor 66 Neoplasms 54 Thyroid Carcinoma, Anaplastic 50 Adrenocortical Carcinoma 47 Adrenal Gland Neoplasms 46 Neoplasm Metastasis 40 Insulinoma 39 Pancreatic Neoplasms 36 Gastro-enteropancreatic neuroendocrine tumor 36 Adenoma, Islet Cell 36 Carcinoma, Medullary 29 Neuroblastoma 28 Adenocarcinoma, Follicular 28 Hyperaldosteronism 25 Prostatic Neoplasms 24 Lung Neoplasms 24 Obesity 23 Brain Neoplasms 22 Pituitary Diseases 21 Differentiated Thyroid Cancer 20 Cushing Syndrome 20 Sarcoma 19

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cholecystolithiasis × Endocrine × Clear all

NCT04735198 2025-05-20

TNE-IDC-COLE

Hospital Universitari de Bellvitge

Phase NA Recruiting

Neuroendocrine Tumors, Cholecystolithiasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡